{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:48:46Z","timestamp":1770968926978,"version":"3.50.1"},"reference-count":135,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.drudis.2023.103808","type":"journal-article","created":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T05:23:13Z","timestamp":1698556993000},"page":"103808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Harnessing G-quadruplex ligands for lung cancer treatment: A comprehensive overview"],"prefix":"10.1016","volume":"28","author":[{"given":"Joana","family":"Figueiredo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojgan","family":"Djavaheri-Mergny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucille","family":"Ferret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"Mergny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6630-1242","authenticated-orcid":false,"given":"Carla","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2023.103808_b0005","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.drudis.2023.103808_b0010","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 WHO classification of lung tumors: impact of advances since 2015","volume":"17","author":"Nicholson","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.drudis.2023.103808_b0015","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.currproblcancer.2017.07.002","article-title":"Risk factors of lung cancer in nonsmoker","volume":"41","author":"Akhtar","year":"2017","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.drudis.2023.103808_b0020","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","article-title":"The 2015 World Health Organization classification of lung tumors: Impact of genetic, clinical and radiologic advances since the 2004 classification","volume":"10","author":"Travis","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.drudis.2023.103808_b0025","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2023.103808_b0030","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1158\/1078-0432.CCR-18-3904","article-title":"Immunotherapy for the first-line treatment of patients with metastatic non-small cell lung cancer","volume":"25","author":"Martinez","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.drudis.2023.103808_b0035","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1158\/1078-0432.CCR-14-2748","article-title":"Lung cancer in the era of precision medicine","volume":"21","author":"Politi","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.drudis.2023.103808_b0040","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/1947601912465177","article-title":"Cancer genes in lung cancer: racial disparities: are there any?","volume":"3","author":"El-Telbany","year":"2012","journal-title":"Genes Cancer"},{"key":"10.1016\/j.drudis.2023.103808_b0045","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10555-021-09976-0","article-title":"Inhibitors of immune checkpoints\u2014PD-1, PD-L1, CTLA-4\u2014new opportunities for cancer patients and a new challenge for internists and general practitioners","volume":"40","author":"Wojtukiewicz","year":"2021","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.drudis.2023.103808_b0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/1758834011431718","article-title":"Ipilimumab: its potential in non-small cell lung cancer","volume":"4","author":"Tomasini","year":"2012","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.drudis.2023.103808_b0055","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"377","author":"Spigel","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2023.103808_b0060","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer","volume":"386","author":"Forde","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2023.103808_b0065","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2023.103808_b0070","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12943-021-01328-4","article-title":"G-quadruplexes: a promising target for cancer therapy","volume":"20","author":"Kosiol","year":"2021","journal-title":"Mol Cancer"},{"key":"10.1016\/j.drudis.2023.103808_b0075","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1093\/nar\/gkab500","article-title":"G-quadruplex binders as cytostatic modulators of innate immune genes in cancer cells","volume":"49","author":"Miglietta","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2023.103808_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100856","article-title":"A G-quadruplex stabilizer, CX-5461 combined with two immune checkpoint inhibitors enhances in vivo therapeutic efficacy by increasing PD\u2013L1 expression in colorectal cancer","volume":"35","author":"Chung","year":"2023","journal-title":"Neoplasia"},{"key":"10.1016\/j.drudis.2023.103808_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126068","article-title":"Novel phenanthrene imidazoles as telomeric G-quadruplex ligands trigger potent immunogenic cell death in triple-negative breast cancer","volume":"249","author":"Wang","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.drudis.2023.103808_b0090","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2023.103808_b0095","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/344410a0","article-title":"A sodium-potassium switch in the formation of four-stranded G4-DNA","volume":"344","author":"Sen","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2023.103808_b0100","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1073\/pnas.48.12.2013","article-title":"Helix formation by guanylic acid","volume":"48","author":"Gellert","year":"1962","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.drudis.2023.103808_b0105","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1093\/nar\/gkl655","article-title":"Quadruplex DNA: sequence, topology and structure","volume":"34","author":"Burge","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2023.103808_b0110","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrm.2017.3","article-title":"DNA G-quadruplexes in the human genome: detection, functions and therapeutic potential","volume":"18","author":"H\u00e4nsel-Hertsch","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.drudis.2023.103808_b0115","doi-asserted-by":"crossref","first-page":"6557","DOI":"10.1007\/s00018-021-03921-8","article-title":"G-quadruplex DNA: a novel target for drug design","volume":"78","author":"Teng","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.drudis.2023.103808_b0120","doi-asserted-by":"crossref","first-page":"11593","DOI":"10.1073\/pnas.182256799","article-title":"Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription","volume":"99","author":"Siddiqui-Jain","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.drudis.2023.103808_b0125","doi-asserted-by":"crossref","first-page":"10584","DOI":"10.1021\/ja050823u","article-title":"Putative DNA quadruplex formation within the human c-kit oncogene","volume":"127","author":"Rankin","year":"2005","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.drudis.2023.103808_b0130","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1021\/ja0563861","article-title":"Deconvoluting the structural and drug-recognition complexity of the G-quadruplex-forming region upstream of the bcl-2 P1 promoter","volume":"128","author":"Dexheimer","year":"2006","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.drudis.2023.103808_b0135","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1093\/nar\/gkl286","article-title":"G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcription","volume":"34","author":"Cogoi","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2023.103808_b0140","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1093\/nar\/gki917","article-title":"Facilitation of a structural transition in the polypurine\/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents","volume":"33","author":"Sun","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2023.103808_b0145","doi-asserted-by":"crossref","first-page":"D1115","DOI":"10.1093\/nar\/gks1101","article-title":"G4LDB: a database for discovering and studying G-quadruplex ligands","volume":"41","author":"Li","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2023.103808_b0150","doi-asserted-by":"crossref","first-page":"7653","DOI":"10.1158\/0008-5472.CAN-09-1304","article-title":"Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis","volume":"69","author":"Drygin","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.drudis.2023.103808_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.129016","article-title":"A first-in-class clinical G-quadruplex-targeting drug. The bench-to-bedside translation of the fluoroquinolone QQ58 to CX\u20135461 (Pidnarulex)","volume":"77","author":"Xu","year":"2022","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.drudis.2023.103808_b0160","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1158\/1535-7163.MCT-17-1209","article-title":"APTO-253 stabilizes G-quadruplex DNA, inhibits MYC expression, and induces DNA damage in acute myeloid leukemia cells","volume":"17","author":"Local","year":"2018","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.drudis.2023.103808_b0165","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/s41467-019-08905-8","article-title":"G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma","volume":"10","author":"Wang","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2023.103808_b0170","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nchembio.780","article-title":"Small-molecule-induced DNA damage identifies alternative DNA structures in human genes","volume":"8","author":"Rodriguez","year":"2012","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.drudis.2023.103808_b0175","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.molcel.2015.12.004","article-title":"Targeting BRCA1 and BRCA2 deficiencies with G-quadruplex-interacting compounds","volume":"61","author":"Zimmer","year":"2016","journal-title":"Mol Cell"},{"key":"10.1016\/j.drudis.2023.103808_b0180","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1073\/pnas.1810409116","article-title":"DNA damage and genome instability by G-quadruplex ligands are mediated by R loops in human cancer cells","volume":"116","author":"De Magis","year":"2019","journal-title":"PNAS"},{"key":"10.1016\/j.drudis.2023.103808_b0185","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.2174\/1381612811319120004","article-title":"FDA-approved drugs selected using virtual screening bind specifically to G-quadruplex DNA","volume":"19","author":"Castillo-Gonzalez","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.drudis.2023.103808_b0190","doi-asserted-by":"crossref","first-page":"11059","DOI":"10.1021\/jacs.9b02679","article-title":"Indenoisoquinoline topoisomerase inhibitors strongly bind and stabilize the MYC promoter G-quadruplex and downregulate MYC","volume":"141","author":"Wang","year":"2019","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.drudis.2023.103808_b0195","doi-asserted-by":"crossref","first-page":"609","DOI":"10.21873\/anticanres.13990","article-title":"C-myc contributes to malignancy of lung cancer: a potential anticancer drug target","volume":"40","author":"Chanvorachote","year":"2020","journal-title":"Anticancer Res"},{"key":"10.1016\/j.drudis.2023.103808_b0200","doi-asserted-by":"crossref","first-page":"17034","DOI":"10.1073\/pnas.1207310109","article-title":"A framework for identification of actionable cancer genome dependencies in small cell lung cancer","volume":"109","author":"Sos","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.drudis.2023.103808_b0205","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ccell.2016.12.005","article-title":"MYC drives progression of small cell lung cancer to a variant neuroendocrine subtype with vulnerability to Aurora kinase inhibition","volume":"31","author":"Mollaoglu","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drudis.2023.103808_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103756","article-title":"Therapeutic targeting of \u2018undruggable\u2019 MYC","volume":"75","author":"Llombart","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.drudis.2023.103808_b0215","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev.pharmtox.48.113006.094649","article-title":"The c-MYC NHE III: function and regulation","volume":"50","author":"Gonz\u00e1lez","year":"2010","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.drudis.2023.103808_b0220","article-title":"Human MYC G-quadruplex: from discovery to a cancer therapeutic target. Biochimica et Biophysica Acta (BBA) \u2013 Reviews on","volume":"1874","author":"Wang","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.drudis.2023.103808_b0225","doi-asserted-by":"crossref","first-page":"39239","DOI":"10.1038\/srep39239","article-title":"Evidences for piperine inhibiting cancer by targeting human G-quadruplex DNA sequences","volume":"6","author":"Tawani","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2023.103808_b0230","doi-asserted-by":"crossref","first-page":"22909","DOI":"10.1038\/s41598-021-01529-3","article-title":"Piperine analogs arrest c-myc gene leading to downregulation of transcription for targeting cancer","volume":"11","author":"Pandya","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2023.103808_b0235","article-title":"Anti-cancer activity of benzoxazinone derivatives via targeting c-Myc G-quadruplex structure","volume":"258","author":"Jiang","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.drudis.2023.103808_b0240","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1021\/jm0610088","article-title":"Stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc by quindoline derivatives","volume":"50","author":"Ou","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2023.103808_b0245","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1021\/acs.jmedchem.7b00016","article-title":"Discovery of novel 11-triazole substituted benzofuroquinolone derivatives as c-myc G-quadruplex specific stabilizers via click chemistry","volume":"60","author":"Zeng","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2023.103808_b0250","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.985363","article-title":"The role of BCL-2 family proteins in regulating apoptosis and cancer therapy","volume":"12","author":"Qian","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.drudis.2023.103808_b0255","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrm2312","article-title":"Apoptosis: controlled demolition at the cellular level","volume":"9","author":"Taylor","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.drudis.2023.103808_b0260","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1136\/jcp.2005.031351","article-title":"Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation","volume":"59","author":"Zhu","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.drudis.2023.103808_b0265","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.1158\/0008-5472.CAN-04-4570","article-title":"Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2","volume":"65","author":"Choi","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.drudis.2023.103808_b0270","doi-asserted-by":"crossref","first-page":"7662","DOI":"10.1158\/1078-0432.CCR-04-1036","article-title":"Antitumor efficacy of oblimersen Bcl-2 antisense oligonucleotide alone and in combination with vinorelbine in xenograft models of human non-small cell lung cancer","volume":"10","author":"Hu","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.drudis.2023.103808_b0275","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bbcan.2017.06.004","article-title":"BCL2: a promising cancer therapeutic target","volume":"1868","author":"Radha","year":"2017","journal-title":"Biochimica et Biophysica Acta (BBA) \u2013 Rev Cancer"},{"key":"10.1016\/j.drudis.2023.103808_b0280","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3109\/10428190109097729","article-title":"Causes and consequences of BCL2 overexpression in diffuse large B-cell lymphoma","volume":"42","author":"Rantanen","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.drudis.2023.103808_b0285","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/ja4118945","article-title":"The major G-quadruplex formed in the human BCL-2 proximal promoter adopts a parallel structure with a 13-nt loop in K in K+ solution","volume":"136","author":"Agrawal","year":"2014","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.drudis.2023.103808_b0290","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1093\/nar\/gkl610","article-title":"NMR solution structure of the major G-quadruplex structure formed in the human BCL2 promoter region","volume":"34","author":"Dai","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2023.103808_b0295","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1021\/jacs.5b08596","article-title":"A new G-quadruplex with hairpin loop immediately upstream of the human BCL2 P1 promoter modulates transcription","volume":"138","author":"Onel","year":"2016","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.drudis.2023.103808_b0300","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.drudis.2022.06.002","article-title":"BCL2 G quadruplex-binding small molecules: current status and prospects for the development of next-generation anticancer therapeutics","volume":"27","author":"Singh","year":"2022","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2023.103808_b0305","doi-asserted-by":"crossref","first-page":"10394","DOI":"10.7150\/thno.48675","article-title":"Recognition of G-quadruplex topology through hybrid binding with implications in cancer theranostics","volume":"10","author":"Suseela","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.drudis.2023.103808_b0310","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3390\/molecules22050829","article-title":"Microwave-assisted synthesis of imidazophenanthroline derivatives as apoptosis inducers in chemotherapy by stabilizing Bcl-2 G-quadruplex DNA","volume":"22","author":"Li","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2023.103808_b0315","article-title":"Interaction analysis of anti-cancer drug Methotrexate with bcl\u20132 promoter stabilization and its transcription regulation","volume":"23","author":"Pandya","year":"2021","journal-title":"Gene Rep"},{"key":"10.1016\/j.drudis.2023.103808_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120651","article-title":"Design, synthesis and bioactivity of novel naphthalimide-benzotriazole conjugates against A549 cells via targeting BCL2 G-quadruplex and inducing autophagy","volume":"302","author":"Wang","year":"2022","journal-title":"Life Sci"},{"key":"10.1016\/j.drudis.2023.103808_b0325","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13073-016-0324-x","article-title":"Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies","volume":"8","author":"Jafri","year":"2016","journal-title":"Genome Med"},{"key":"10.1016\/j.drudis.2023.103808_b0330","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1200\/JCO.2004.01.091","article-title":"Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers","volume":"22","author":"Lu","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.drudis.2023.103808_b0335","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.bmc.2012.12.020","article-title":"Telomere shortening and cell senescence induced by perylene derivatives in A549 human lung cancer cells","volume":"21","author":"Taka","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.drudis.2023.103808_b0340","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1021\/jm970199z","article-title":"Inhibition of human telomerase by a G-Quadruplex-Interactive compound","volume":"40","author":"Sun","year":"1997","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2023.103808_b0345","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/3949","article-title":"G-quadruplex DNA: a target for drug design","volume":"4","author":"Mergny","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.drudis.2023.103808_b0350","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1021\/acs.bioconjchem.7b00781","article-title":"Human telomeric G-quadruplex selective fluoro-isoquinolines induce apoptosis in cancer cells","volume":"29","author":"Maiti","year":"2018","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.drudis.2023.103808_b0355","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejmech.2017.03.030","article-title":"Synthesis and the interaction of 2-(1H-pyrazol-4-yl)-1H-imidazo[4,5-f][1,10]phenanthrolines with telomeric DNA as lung cancer inhibitors","volume":"133","author":"Liu","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.drudis.2023.103808_b0360","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ejmech.2019.06.012","article-title":"Design, synthesis of 4,5-diazafluorene derivatives and their anticancer activity via targeting telomeric DNA G-quadruplex","volume":"178","author":"Zhou","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.drudis.2023.103808_b0365","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1021\/acsomega.6b00523","article-title":"Naphthalenediimide-linked bisbenzimidazole derivatives as telomeric G-quadruplex-stabilizing ligands with improved anticancer activity","volume":"2","author":"Sur","year":"2017","journal-title":"ACS Omega"},{"key":"10.1016\/j.drudis.2023.103808_b0370","doi-asserted-by":"crossref","first-page":"9397","DOI":"10.1039\/C7NJ02366A","article-title":"Synthesis, G-quadruplex binding properties and cytotoxicity of naphthalimide-thiourea conjugates","volume":"41","author":"Ou","year":"2017","journal-title":"New J Chem"},{"key":"10.1016\/j.drudis.2023.103808_b0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2020.119318","article-title":"New 2,9-disubstituted-1,10-phenanthroline derivatives with anticancer activity by selective targeting of telomeric G-quadruplex DNA","volume":"249","author":"Craciun","year":"2021","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"10.1016\/j.drudis.2023.103808_b0380","doi-asserted-by":"crossref","first-page":"6154","DOI":"10.1039\/c1ob05560g","article-title":"Unraveling the relationship between structure and stabilization of triarylpyridines as G-quadruplex binding ligands","volume":"9","author":"Smith","year":"2011","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.drudis.2023.103808_b0385","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/nar\/gkz095","article-title":"Modulation of the ATM\/autophagy pathway by a G-quadruplex ligand tips the balance between senescence and apoptosis in cancer cells","volume":"47","author":"Beauvarlet","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2023.103808_b0390","doi-asserted-by":"crossref","first-page":"1604047","DOI":"10.1080\/23723556.2019.1604047","article-title":"Activation of the ataxia telangiectasia mutated\/autophagy pathway by a G-quadruplex ligand links senescence with apoptosis","volume":"6","author":"Beauvarlet","year":"2019","journal-title":"Mol Cell Oncol"},{"key":"10.1016\/j.drudis.2023.103808_b0395","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.3390\/cancers12061621","article-title":"Triarylpyridine compounds and chloroquine act in concert to trigger lysosomal membrane permeabilization and cell death in cancer cells","volume":"12","author":"Beauvarlet","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.drudis.2023.103808_b0400","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1093\/nar\/gkaa107","article-title":"The hTERT core promoter forms three parallel G-quadruplexes","volume":"48","author":"Monsen","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2023.103808_b0405","doi-asserted-by":"crossref","first-page":"16255","DOI":"10.1038\/srep16255","article-title":"Highly efficient radiosensitization of human glioblastoma and lung cancer cells by a G-quadruplex DNA binding compound","volume":"5","author":"Merle","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2023.103808_b0410","first-page":"2241","article-title":"Expression and prognostic significance of Kit, protein kinase B, and mitogen-activated protein kinase in patients with small cell lung cancer","volume":"9","author":"Blackhall","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.drudis.2023.103808_b0415","doi-asserted-by":"crossref","first-page":"13399","DOI":"10.1021\/ja904007p","article-title":"A G-rich sequence within the c-kit oncogene promoter forms a parallel G-quadruplex having asymmetric G-tetrad dynamics","volume":"131","author":"Hsu","year":"2009","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.drudis.2023.103808_b0420","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ccr.2011.04.002","article-title":"c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma","volume":"19","author":"Blasco","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drudis.2023.103808_b0425","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/35074129","article-title":"Somatic activation of the K-ras oncogene causes early onset lung cancer in mice","volume":"410","author":"Johnson","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2023.103808_b0430","doi-asserted-by":"crossref","first-page":"8082","DOI":"10.1074\/jbc.M117.781906","article-title":"High-resolution three-dimensional NMR structure of the KRAS proto-oncogene promoter reveals key features of a G-quadruplex involved in transcriptional regulation","volume":"292","author":"Kerkour","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2023.103808_b0435","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1093\/nar\/gkn120","article-title":"Structural polymorphism within a regulatory element of the human KRAS promoter: formation of G4-DNA recognized by nuclear proteins","volume":"36","author":"Cogoi","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2023.103808_b0440","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1080\/14728222.2017.1371137","article-title":"VEGF as a potential target in lung cancer","volume":"21","author":"Frezzetti","year":"2017","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.drudis.2023.103808_b0445","doi-asserted-by":"crossref","first-page":"e0211046","DOI":"10.1371\/journal.pone.0211046","article-title":"Quadruplex-forming oligonucleotide targeted to the VEGF promoter inhibits growth of non-small cell lung cancer cells","volume":"14","author":"Muench","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2023.103808_b0450","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bmcl.2011.10.089","article-title":"Down-regulation of the human VEGF gene expression by perylene monoimide derivatives","volume":"22","author":"Taka","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.drudis.2023.103808_b0455","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s43018-021-00195-8","article-title":"Overcoming therapy resistance in EGFR-mutant lung cancer","volume":"2","author":"Passaro","year":"2021","journal-title":"Nat Cancer"},{"key":"10.1016\/j.drudis.2023.103808_b0460","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ejmech.2019.05.066","article-title":"Distinct biological responses of metastatic castration resistant prostate cancer cells upon exposure to G-quadruplex interacting naphthalenediimide derivatives","volume":"177","author":"Recagni","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.drudis.2023.103808_b0465","doi-asserted-by":"crossref","first-page":"16228","DOI":"10.1021\/jacs.3c05214","article-title":"Structure of the major G-quadruplex in the human EGFR oncogene promoter adopts a unique folding topology with a distinctive snap-back loop","volume":"145","author":"Liu","year":"2023","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.drudis.2023.103808_b0470","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1021\/acscentsci.5b00202","article-title":"A role for the fifth G-track in G-quadruplex forming oncogene promoter sequences during oxidative stress: do these \u2018spare tires\u2019 have an evolved function?","volume":"1","author":"Fleming","year":"2015","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.drudis.2023.103808_b0475","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1093\/nar\/gkz207","article-title":"Location dependence of the transcriptional response of a potential G-quadruplex in gene promoters under oxidative stress","volume":"47","author":"Fleming","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2023.103808_b0480","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/JTO.0b013e31820c5189","article-title":"Aberrant Wnt1\/\u03b2-catenin expression is an independent poor prognostic marker of non-small cell lung cancer after surgery","volume":"6","author":"Xu","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.drudis.2023.103808_b0485","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/\u03b2-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2023.103808_b0490","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1021\/ja5089327","article-title":"Conformational transition of a hairpin structure to G-quadruplex within the WNT1 gene promoter","volume":"137","author":"Kuo","year":"2015","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.drudis.2023.103808_b0495","doi-asserted-by":"crossref","first-page":"67986","DOI":"10.18632\/oncotarget.6622","article-title":"Identification of a new class of WNT1 inhibitor: cancer cells migration, G-quadruplex stabilization and target validation","volume":"7","author":"Chang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.drudis.2023.103808_b0500","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.molstruc.2019.02.073","article-title":"Novel triazole and morpholine substituted bisnaphthalimide: synthesis, photophysical and G-quadruplex binding properties","volume":"1185","author":"Ou","year":"2019","journal-title":"J Mol Struct"},{"key":"10.1016\/j.drudis.2023.103808_b0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111627","article-title":"Targeting multiple G-quadruplex-forming DNA sequences: Design, biophysical and biological evaluations of indolo-naphthyridine scaffold derivatives","volume":"182","author":"Catalano","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.drudis.2023.103808_b0510","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1038\/s41467-022-33761-4","article-title":"Structural insight into the bulge-containing KRAS oncogene promoter G-quadruplex bound to berberine and coptisine","volume":"13","author":"Wang","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2023.103808_b0515","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bcp.2009.03.018","article-title":"G-quadruplex compounds and cis-platin act synergistically to inhibit cancer cell growth in vitro and in vivo","volume":"78","author":"Gunaratnam","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.drudis.2023.103808_b0520","doi-asserted-by":"crossref","first-page":"e46793","DOI":"10.7554\/eLife.46793","article-title":"Genetic interactions of G-quadruplexes in humans","volume":"8","author":"Zyner","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.drudis.2023.103808_b0525","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/MCP.0b013e32816b5c63","article-title":"ERCC1 as a risk stratifier in platinum-based chemotherapy for nonsmall-cell lung cancer","volume":"13","author":"Olaussen","year":"2007","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.drudis.2023.103808_b0530","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.isci.2019.05.017","article-title":"ERCC1\/XPF is important for repair of DNA double-strand breaks containing secondary structures","volume":"16","author":"Li","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.drudis.2023.103808_b0535","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nchembio.780","article-title":"Small-molecule-induced DNA damage identifies alternative DNA structures in human genes","volume":"8","author":"Rodriguez","year":"2012","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.drudis.2023.103808_b0540","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1038\/s41467-019-11104-0","article-title":"Involvement of G-quadruplex regions in mammalian replication origin activity","volume":"10","author":"Prorok","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2023.103808_b0545","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.3390\/molecules24193439","article-title":"Mechanisms of DNA replication and repair: insights from the study of G-quadruplexes","volume":"24","author":"Bryan","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2023.103808_b0550","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41556-018-0244-7","article-title":"The lysosome as a cellular centre for signalling, metabolism and quality control","volume":"21","author":"Lawrence","year":"2019","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.drudis.2023.103808_b0555","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1038\/onc.2012.292","article-title":"Cancer-associated lysosomal changes: friends or foes?","volume":"32","author":"Kallunki","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.drudis.2023.103808_b0560","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1242\/jcs.091181","article-title":"Lysosomal cell death at a glance","volume":"126","author":"Aits","year":"2013","journal-title":"J Cell Sci"},{"key":"10.1016\/j.drudis.2023.103808_b0565","doi-asserted-by":"crossref","first-page":"e0184922","DOI":"10.1371\/journal.pone.0184922","article-title":"Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells","volume":"12","author":"Circu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2023.103808_b0570","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1039\/c3ib40058a","article-title":"Chemical principles for the design of a novel fluorescent probe with high cancer-targeting selectivity and sensitivity","volume":"5","author":"Kang","year":"2013","journal-title":"Integr Biol"},{"key":"10.1016\/j.drudis.2023.103808_b0575","doi-asserted-by":"crossref","first-page":"16174","DOI":"10.1002\/chem.201404845","article-title":"Redesigning the DNA-targeted chromophore in platinum-acridine anticancer agents: a structure-activity relationship study","volume":"20","author":"Pickard","year":"2014","journal-title":"Chem A Eur J"},{"key":"10.1016\/j.drudis.2023.103808_b0580","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1080\/15548627.2023.2170071","article-title":"G-quadruplex ligands as potent regulators of lysosomes","volume":"19","author":"Ferret","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.drudis.2023.103808_b0585","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.semcancer.2020.03.010","article-title":"Autophagy in cancer: recent advances and future directions","volume":"66","author":"Ishaq","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.drudis.2023.103808_b0590","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.4161\/auto.20519","article-title":"Autophagy acts as a safeguard mechanism against G-quadruplex ligand-mediated DNA damage","volume":"8","author":"Orlotti","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.drudis.2023.103808_b0595","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1242\/jcs.146365","article-title":"TFEB at a glance","volume":"129","author":"Napolitano","year":"2016","journal-title":"J Cell Sci"},{"key":"10.1016\/j.drudis.2023.103808_b0600","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016907","article-title":"Lysosomal adaptation: how the lysosome responds to external cues","volume":"6","author":"Settembre","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.drudis.2023.103808_b0605","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.tig.2022.10.006","article-title":"Mitochondria and G-quadruplex evolution: an intertwined relationship","volume":"39","author":"Sahayasheela","year":"2023","journal-title":"Trends Genet"},{"key":"10.1016\/j.drudis.2023.103808_b0610","first-page":"10102","article-title":"Direct evidence of mitochondrial G-quadruplex DNA by using fluorescent anti-cancer agents","volume":"43","author":"Huang","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2023.103808_b0615","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1038\/s41598-019-41464-y","article-title":"G-quadruplex dynamics contribute to regulation of mitochondrial gene expression","volume":"9","author":"Falabella","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2023.103808_b0620","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.molmed.2020.05.002","article-title":"G-quadruplex, friend or foe: the role of the G-quartet in anticancer strategies","volume":"26","author":"Carvalho","year":"2020","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.drudis.2023.103808_b0625","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.3390\/molecules24203781","article-title":"G-quadruplex-forming aptamers\u2014characteristics, applications, and perspectives","volume":"24","author":"Roxo","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2023.103808_b0630","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s10637-013-0045-6","article-title":"A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma","volume":"32","author":"Rosenberg","year":"2014","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.drudis.2023.103808_b0635","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.molonc.2015.03.012","article-title":"Mechanistic studies of anticancer aptamer AS1411 reveal a novel role for nucleolin in regulating Rac1 activation","volume":"9","author":"Reyes-Reyes","year":"2015","journal-title":"Mol Oncol"},{"key":"10.1016\/j.drudis.2023.103808_b0640","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1158\/1535-7163.MCT-06-0172","article-title":"Discovery and development of anticancer aptamers","volume":"5","author":"Ireson","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.drudis.2023.103808_b0645","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1186\/s11671-016-1652-x","article-title":"G4-Tetra DNA duplex induce lung cancer cell apoptosis in A549 cells","volume":"11","author":"Xu","year":"2016","journal-title":"Nanoscale Res Lett"},{"key":"10.1016\/j.drudis.2023.103808_b0650","doi-asserted-by":"crossref","first-page":"6603","DOI":"10.1158\/0008-5472.CAN-03-4041","article-title":"G-quartet oligonucleotides: a new class of signal transducer and activator of transcription 3 inhibitors that suppresses growth of prostate and breast tumors through induction of apoptosis","volume":"64","author":"Jing","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.drudis.2023.103808_b0655","first-page":"129","article-title":"Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides","volume":"31","author":"Weerasinghe","year":"2007","journal-title":"Int J Oncol"},{"key":"10.1016\/j.drudis.2023.103808_b0660","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1039\/B714772B","article-title":"A hitchhiker\u2019s guide to G-quadruplex ligands","volume":"6","author":"Monchaud","year":"2008","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.drudis.2023.103808_b0665","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.3390\/pharmaceutics14112361","article-title":"Insights into the small molecule targeting of biologically relevant G-quadruplexes: an overview of NMR and crystal structures","volume":"14","author":"Criscuolo","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.drudis.2023.103808_b0670","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.biochi.2022.12.019","article-title":"Guidelines for G-quadruplexes: I. In vitro characterization","volume":"214","author":"Luo","year":"2023","journal-title":"Biochimie"},{"key":"10.1016\/j.drudis.2023.103808_b0675","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.3390\/cancers15153817","article-title":"G4-QuadScreen: a computational tool for identifying multi-target-directed anticancer leads against G-quadruplex DNA","volume":"15","author":"Bhat-Ambure","year":"2023","journal-title":"Cancers (Basel)"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644623003240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644623003240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:09:33Z","timestamp":1761224973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644623003240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":135,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1359644623003240"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2023.103808","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harnessing G-quadruplex ligands for lung cancer treatment: A comprehensive overview","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2023.103808","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103808"}}